The COQ2 gene plays a critical role in the body by contributing to the production of Coenzyme Q10 (CoQ10), a substance essential for the proper functioning of cells and the generation of energy within the mitochondria. Mutations in the COQ2 gene can lead to Coenzyme Q10 deficiency type 1, a condition that affects various systems of the body and can lead to symptoms such as muscle weakness, seizures, and neurological impairments.
To diagnose this genetic condition, a specific genetic test can be performed that analyzes the COQ2 gene for mutations. This test is crucial for confirming the diagnosis of Coenzyme Q10 deficiency type 1, allowing for appropriate treatment and management strategies to be implemented. Treatment often involves supplementation with CoQ10, which can help alleviate some of the symptoms associated with the deficiency.
In the United Arab Emirates, DNA Labs UAE offers the COQ2 Gene Coenzyme Q10 Deficiency Type 1 Genetic Test. The cost of the test is 4400 AED. DNA Labs UAE is known for its state-of-the-art facilities and expert team of geneticists and medical professionals who ensure accurate and reliable test results. Opting for this test at DNA Labs UAE can provide individuals and families with crucial information regarding the presence of COQ2 gene mutations, guiding healthcare decisions and improving patient outcomes.
The PDSS1 Gene Coenzyme Q10 Deficiency Type 2 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the PDSS1 gene, which are associated with Coenzyme Q10 Deficiency Type 2. This condition is a rare genetic disorder that affects the body's ability to produce Coenzyme Q10 (CoQ10), a substance crucial for energy production within cells and the protection of cells from oxidative damage. Symptoms of the deficiency can vary widely but may include muscle weakness, seizures, and neurological problems.
The test is conducted through a blood sample or a cheek swab, which is then analyzed for specific genetic mutations in the PDSS1 gene. Identifying these mutations can be critical for confirming a diagnosis, allowing for appropriate management and treatment strategies to be implemented. This can include CoQ10 supplementation and supportive therapies tailored to alleviate symptoms and improve quality of life for affected individuals.
The cost of the PDSS1 Gene Coenzyme Q10 Deficiency Type 2 Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to accurately identify mutations in the PDSS1 gene. For patients and families facing the possibility of Coenzyme Q10 Deficiency Type 2, this test represents a crucial step in understanding and managing the condition.
The PDSS2 Gene Coenzyme Q10 Deficiency Type 3 Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to detect mutations in the PDSS2 gene, which are linked to Coenzyme Q10 Deficiency Type 3. This rare, autosomal recessive disorder disrupts the body's ability to produce Coenzyme Q10 (CoQ10), an essential molecule for energy production and antioxidant protection in cells. Symptoms of the deficiency can vary but often include neurological and muscular manifestations, such as seizures, muscle weakness, and ataxia.
The test involves analyzing the patient's DNA to identify any genetic alterations in the PDSS2 gene that may lead to the condition. This is crucial for confirming the diagnosis, understanding the disease's progression, and guiding treatment options. Early diagnosis and intervention can significantly improve the quality of life for affected individuals, making this test an invaluable tool for those with suspected Coenzyme Q10 Deficiency.
The cost of the PDSS2 Gene Coenzyme Q10 Deficiency Type 3 Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive analysis required to accurately assess the presence of genetic mutations associated with the condition. By choosing DNA Labs UAE for this testing, patients can expect state-of-the-art facilities, highly qualified geneticists, and reliable results, all contributing to effective disease management and treatment planning.
The COQ9 gene coenzyme Q10 deficiency type 5 genetic test is a specialized diagnostic procedure designed to identify mutations in the COQ9 gene, which are associated with a rare form of coenzyme Q10 deficiency. This condition is a mitochondrial disorder that can affect multiple systems of the body, leading to symptoms such as muscle weakness, seizures, and intellectual disabilities. Early detection through genetic testing is crucial for the management and treatment of the condition, as it can help in tailoring specific therapies that may improve the quality of life for affected individuals.
The test is conducted at DNA Labs UAE, a reputable facility known for its comprehensive genetic testing services. The cost of the COQ9 gene coenzyme Q10 deficiency type 5 genetic test is 4400 AED. This investment covers the process of collecting a DNA sample, usually through a blood draw or a cheek swab, and the subsequent laboratory analysis to detect any genetic mutations associated with the condition. Results from this test can provide valuable information for affected individuals and their families, guiding medical decisions and potential interventions.
The RPS6KA3 gene Coffin-Lowry Syndrome genetic test is a specialized diagnostic procedure aimed at identifying mutations in the RPS6KA3 gene, which are responsible for causing Coffin-Lowry Syndrome (CLS). CLS is a rare genetic disorder that affects intellectual development and physical growth, with symptoms including cognitive impairments, skeletal anomalies, and distinctive facial features. This test is crucial for families seeking a definitive diagnosis of CLS, enabling informed decisions about management and care.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing it for specific genetic alterations associated with the syndrome. The cost of the test is set at 4400 AED, reflecting the specialized nature of the analysis and the expertise required to accurately interpret the results.
For families with a history of Coffin-Lowry Syndrome or individuals showing symptoms consistent with the disorder, this genetic test provides a critical tool for diagnosis, facilitating early intervention and support strategies tailored to the unique needs of each patient.
The VPS13B Gene Cohen Syndrome Genetic Test is a specialized diagnostic examination designed to identify mutations in the VPS13B gene, which are responsible for causing Cohen Syndrome. This rare genetic disorder is characterized by developmental delay, intellectual disability, small head size (microcephaly), and distinctive facial features, among other symptoms. The test is a crucial tool for clinicians to accurately diagnose Cohen Syndrome, enabling appropriate management and support for affected individuals and their families.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test employs advanced genetic sequencing technologies to scrutinize the VPS13B gene for any abnormalities that are indicative of Cohen Syndrome. The process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the lab for the presence of mutations.
The cost of the VPS13B Gene Cohen Syndrome Genetic Test is set at 4400 AED. This price reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to accurately identify mutations in the VPS13B gene. For families and individuals considering this test, it represents a significant step towards understanding and managing Cohen Syndrome, offering insights that can guide treatment decisions and support services.
The CNTN1 gene, associated with Compton-North Congenital Myopathy, plays a crucial role in the development and function of the nervous system. Mutations in this gene can lead to a range of neuromuscular disorders, including Compton-North Congenital Myopathy, which is characterized by muscle weakness and developmental issues from birth. Recognizing the significance of early and accurate diagnosis for effective management and treatment, DNA Labs UAE offers a specialized genetic test targeting the CNTN1 gene.
The test is designed to identify mutations within the CNTN1 gene that could indicate the presence of Compton-North Congenital Myopathy, providing vital information for healthcare providers and affected families. This precise genetic analysis is crucial for confirming the diagnosis, understanding the condition's progression, and exploring potential treatment options tailored to the individual's genetic makeup.
Conducted in a state-of-the-art facility, the test is available for a cost of 4400 AED. DNA Labs UAE ensures that the process is handled with the utmost care and professionalism, delivering reliable and timely results. By opting for this genetic test, patients and their families can gain insights into the genetic underpinnings of Compton-North Congenital Myopathy, paving the way for a more informed approach to care and management.
The B3GALNT2 gene plays a critical role in the proper development and function of muscles and the brain, primarily due to its involvement in the glycosylation process of α-dystroglycan. Mutations in this gene can lead to a form of congenital muscular dystrophy, characterized by muscle weakness and brain abnormalities, along with a reduction in the glycosylation of α-dystroglycan - a key protein that connects the cytoskeleton of a muscle fiber to the surrounding extracellular matrix.
The genetic test for identifying mutations in the B3GALNT2 gene is crucial for diagnosing this specific subtype of congenital muscular dystrophy and its associated hypoglycosylation of α-dystroglycan. This test provides essential information for understanding the disease's progression, potential interventions, and management strategies for affected individuals.
Conducted at DNA Labs UAE, the test is priced at 4400 AED. DNA Labs UAE is known for its state-of-the-art facilities and expertise in genetic diagnostics, ensuring high accuracy and reliability of the test results. The test involves analyzing the patient's DNA to detect mutations in the B3GALNT2 gene that could lead to the disease, providing a critical tool for early diagnosis and the possibility of better clinical outcomes through timely and appropriate interventions.
The EGR2 Gene CMT4E Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the EGR2 gene, which are known to cause Charcot-Marie-Tooth disease type 4E (CMT4E), a rare and severe form of hereditary motor and sensory neuropathy. This condition is characterized by progressive muscle weakness and atrophy, sensory loss, and in some cases, severe neurological impairments. Early detection through genetic testing is crucial for the management and treatment of the disease, allowing for personalized care plans and genetic counseling for affected families.
DNA Labs UAE offers this comprehensive genetic test, employing advanced molecular techniques to accurately detect mutations in the EGR2 gene. The test is priced at 4400 AED, reflecting the intricate process of genetic analysis and the specialized expertise required to interpret the results. By choosing to undergo this test at DNA Labs UAE, patients and their families can expect high-quality service, detailed results, and professional guidance, aiding them in understanding their genetic health and making informed decisions about their care.
The MPZ Gene CMT4E Genetic Test is a specialized diagnostic procedure designed to identify mutations in the MPZ gene, which are associated with Charcot-Marie-Tooth disease type 4E (CMT4E). CMT4E is a rare form of Charcot-Marie-Tooth disease, a neurological disorder that affects the peripheral nerves, leading to muscle weakness and sensory problems. The MPZ gene plays a crucial role in the functioning and structure of peripheral nerves, and mutations in this gene can disrupt nerve function, resulting in the symptoms of CMT4E.
This genetic test involves analyzing the patient's DNA to look for specific mutations in the MPZ gene that are known to cause CMT4E. It is a critical tool for confirming a diagnosis of CMT4E, enabling healthcare providers to tailor treatment plans and management strategies to the individual's condition. Furthermore, identifying the mutation can also provide valuable information for family planning and genetic counseling for affected families.
The MPZ Gene CMT4E Genetic Test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the test is 4400 AED. By offering this test, DNA Labs UAE aims to provide patients and their families with access to crucial information that can significantly impact the management of Charcot-Marie-Tooth disease type 4E, ultimately improving patient outcomes and quality of life.
